Orlistat in the treatment of Type 2 diabetes mellitus

Author： Jneidi Muna   Kelley David E  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.5, 2002-05, pp. : 599-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Orlistat gains merit in type 2 diabetes mellitus

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus

By Maetzel A.  

PharmacoEconomics, Vol. 21, Iss. 7, 2003-01 ,pp. : 501-512

Adis International

Access to resources Recommend Favorite

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes

By Nelson Robert H   Miles John M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2483-2491

Informa Healthcare

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.  

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite